- Home
- TORO vs DYAI Comparison
TORO vs DYAI Comparison
Compare TORO & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- DYAI
- Stock Information
- Founded
- TORO 2022
- DYAI 1979
- Country
- TORO Cyprus
- DYAI United States
- Employees
- TORO N/A
- DYAI N/A
- Industry
- TORO Marine Transportation
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TORO Consumer Discretionary
- DYAI Health Care
- Exchange
- TORO Nasdaq
- DYAI Nasdaq
- Market Cap
- TORO 36.7M
- DYAI 30.2M
- IPO Year
- TORO N/A
- DYAI 2004
- Fundamental
- Price
- TORO $2.72
- DYAI $0.95
- Analyst Decision
- TORO
- DYAI Strong Buy
- Analyst Count
- TORO 0
- DYAI 1
- Target Price
- TORO N/A
- DYAI $6.00
- AVG Volume (30 Days)
- TORO 33.0K
- DYAI 124.7K
- Earning Date
- TORO 09-12-2025
- DYAI 08-13-2025
- Dividend Yield
- TORO N/A
- DYAI N/A
- EPS Growth
- TORO N/A
- DYAI N/A
- EPS
- TORO N/A
- DYAI N/A
- Revenue
- TORO $21,513,733.00
- DYAI $4,135,078.00
- Revenue This Year
- TORO N/A
- DYAI $34.23
- Revenue Next Year
- TORO N/A
- DYAI $19.57
- P/E Ratio
- TORO N/A
- DYAI N/A
- Revenue Growth
- TORO N/A
- DYAI 129.20
- 52 Week Low
- TORO $1.70
- DYAI $0.71
- 52 Week High
- TORO $3.63
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- TORO 46.11
- DYAI 55.15
- Support Level
- TORO $2.69
- DYAI $0.76
- Resistance Level
- TORO $2.82
- DYAI $0.98
- Average True Range (ATR)
- TORO 0.10
- DYAI 0.07
- MACD
- TORO -0.02
- DYAI 0.02
- Stochastic Oscillator
- TORO 19.54
- DYAI 89.52
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.